Quotient Sciences has completed the expansion of its drug substance manufacturing facility in Alnwick, UK. The £6 million expansion includes a state-of-the-art drug substance manufacturing capability to provide integrated support for customers from candidate selection through to early clinical development and beyond.     The facility has multipurpose capacity of up to 15 GMP reactor streams with reactor volumes ranging from 5 liters up to 150 liters and tactical deployment of batch or continuo...